What this trial means for you
This study is recruiting now at 2 US sites. It's studying see the official record for diabetes mellitus.
What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.
The study, in the sponsor's words
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
Can you join? The exact criteria
Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.
Full eligibility criteria (for you and your doctor)
Inclusion Criteria: 1. Subject must be at least 18 years of age. 2. Subject must be able to read and understand English. 3. Subject must have a type 2 diabetes diagnosis. 4. In the investigator's opinion, subject must meet the criteria for beginning use of GLP-1 or GIP/GLP-1 medications for management of their diabetes. 5. Subject is beginning use of GLP-1 / GIP/GLP-1 medication for management of their diabetes. 6. Subject must be willing to allow venous samples to be obtained to test HbA1c. 7. Subject must be willing to either continue using their existing standard of care device or must be willing to use the FreeStyle Libre 3 Continuous Glucose Monitoring System to manage their diabetes throughout the duration of the study. 8. In the investigator's opinion, the subject must be able to follow the instructions provided to him/her by the study site and perform all study tasks as specified by the protocol. 9. Subject must be available to participate in all study visits. 10. Subject must be willing and able to provide written signed and dated informed consent. Exclusion Criteria: 11. Subject is a member of the Study Staff. 12. Subject has a diagnosis of type 1 or gestational diabetes. 13. Subject is currently using or has previously used GLP-1 or GIP/GLP-1 drugs for any reason. 14. Subject is currently using a Continuous Glucose Monitor (CGM) as their standard of care device to manage their diabetes. 15. Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin. 16. Subject is taking any type of rapid-acting insulin, including Neutral Protamine Hagedorn (NPH) and premix insulin. 17. Subject has concomitant medical condition which, in the opinion of the investigator, could interfere with the study or present a risk to the safety or welfare of the subject or study staff. 18. Subject currently is participating in another clinical trial. 19. Subject is unsuitable for participation due to any other cause as determined by the Investigator
Study sites by state
Florida
- East Coast Institute for Research, LLC — Jacksonville · Recruiting now
- Excellence Medical and Research — Miami Gardens · Recruiting now
View the official record on ClinicalTrials.gov →
Follow this trial
Get an email when our monthly digest covers enrollment changes and results for trials like this one.
Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in
.env to activate this form.)